Effectiveness of a Tailored Community-Based Exercise Program for Improving Chinese Community-Dwelling Older Adults' Physical Fitness: A Randomized Controlled Trial.
文献摘要
Objective The objective of this study was to evaluate the effectiveness of a tailored community-based exercise program for improving physical capability in community-dwelling older adults living with chronic diseases. Methods This was a two-group, randomized controlled trial conducted in a Chinese community health service center in Guangzhou city. A total of 51 adults (≥60 years) with at least one chronic disease were randomly assigned to the intervention group (n = 25) or control group (n = 26). The intervention was a tailored weekly, physiotherapy-delivered, community-based exercise program for 12 weeks based on the modified Otago Exercise Program. The control group received a home exercise program. Gait speed, functional reach test, timed up and go test, handgrip strength, and EQ5D3L were performed at baseline and 12 weeks after intervention. Results The intervention group showed significantly improved gait speed (compared with the control group-mean difference 0.14 m/s; 95% confidence interval, CI, [0.04, 0.26], p = .009). The intervention group made significant improvements in the functional reach test (mean difference 5.46 cm; 95% CI [1.70, 9.22]; mean difference p = .004), timed up and go test (mean difference -1.09 s; 95% CI [-3.69, -0.32], p = .042), and EQ5D5L (mean difference 0.04; 95% CI [0.01, 0.07], p = .005) compared with the control group. Improvements in gait speed, balance, and quality of life reached minimum clinically important differences. Conclusion A tailored community exercise program effectively improved physical capability for older Chinese adults living with chronic diseases. Significance The findings provide strong evidence for using the modified Otago Exercise Program in community health service center as an implementation strategy to promote healthy aging through accessible, community-based interventions. Registration This study was registered with the Chinese Clinical Trial Registry Center (registry number: ChiCTR2400080071).